Mri-targeted biopsy

Mri-targeted biopsy has been studied in 2 papers since 2026: none in people yet, 1 review; 2 in the past year. No study of it in people or animals has been published yet. The newest story, Nov 12, 2026: “Prostate screening trade-offs worsen with age in models”.

Exposure

2 papers study itUpdated

2 new papers in 30 daysSee all 2 papers on mri-targeted biopsy

  • In silico1

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 12 papers in 12 months
Cancer

Prostate screening trade-offs worsen with age in models

Models estimated 2.7–3.1 overdiagnoses per prostate cancer death prevented at 72 versus 4.5–5.1 at 76 in men without other illnesses.Models estimated 2.7–3.1 overdiagnoses per prostate cancer death prevented at 72 versus 4.5–5.1 at 76 in men without other illnesses.

Computational studyInterventions